DAX group: Bayer achieves important success in dispute with glyphosate plaintiffs
⚡ Quick Summary
The out-of-court settlement for $7.25 billion will not be examined in California, which is critical of Bayer.
The out-of-court settlement for $7.25 billion will not be examined in California, which is critical of Bayer. This increases the chances for the DAX group. The stock is rising.
📰 Related Articles
Japan: Antitrust authorities are investigating ice cream manufacturers on suspicion of collusion
Der Spiegel
Revision in the Berlin rape case: Did Marvin S. want to drug his victim in order to rape her?
Der Spiegel
US interest rate decision: The Fed leaves the key interest rate unchanged
FAZ
Fed: US-Notenbank lässt Leitzins unverändert
Die Zeit
Kevin Warsh: New Fed chief is not touching the US key interest rate for the time being
Der Spiegel